186 related articles for article (PubMed ID: 26113972)
1. Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination.
Yang B; Yang A; Peng S; Pang X; Roden RB; Wu TC; Hung CF
Cell Biosci; 2015; 5():35. PubMed ID: 26113972
[TBL] [Abstract][Full Text] [Related]
2. Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus.
Yang A; Peng S; Farmer E; Zeng Q; Cheng MA; Pang X; Wu TC; Hung CF
Cell Biosci; 2017; 7():46. PubMed ID: 28852471
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination.
Lee SY; Huang Z; Kang TH; Soong RS; Knoff J; Axenfeld E; Wang C; Alvarez RD; Chen CS; Hung CF; Wu TC
J Mol Med (Berl); 2013 Oct; 91(10):1221-31. PubMed ID: 23715898
[TBL] [Abstract][Full Text] [Related]
4. Endoplasmic reticulum stress enhances the antigen-specific T cell immune responses and therapeutic antitumor effects generated by therapeutic HPV vaccines.
Lee SY; Oh JY; Kang TH; Shin HS; Cheng MA; Farmer E; Wu TC; Hung CF
J Biomed Sci; 2019 May; 26(1):41. PubMed ID: 31133013
[TBL] [Abstract][Full Text] [Related]
5. Enhancing DNA vaccine potency by co-administration of xenogenic MHC class-I DNA.
Kang TH; Chung JY; Monie A; Pai SI; Hung CF; Wu TC
Gene Ther; 2010 Apr; 17(4):531-40. PubMed ID: 19940864
[TBL] [Abstract][Full Text] [Related]
6. Cluster intradermal DNA vaccination rapidly induces E7-specific CD8+ T-cell immune responses leading to therapeutic antitumor effects.
Peng S; Trimble C; Alvarez RD; Huh WK; Lin Z; Monie A; Hung CF; Wu TC
Gene Ther; 2008 Aug; 15(16):1156-66. PubMed ID: 18401437
[TBL] [Abstract][Full Text] [Related]
7. Comparison of HPV DNA vaccines employing intracellular targeting strategies.
Kim JW; Hung CF; Juang J; He L; Kim TW; Armstrong DK; Pai SI; Chen PJ; Lin CT; Boyd DA; Wu TC
Gene Ther; 2004 Jun; 11(12):1011-8. PubMed ID: 14985791
[TBL] [Abstract][Full Text] [Related]
8. Characterization of HLA-A2-restricted HPV-16 E7-specific CD8(+) T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice.
Peng S; Trimble C; He L; Tsai YC; Lin CT; Boyd DA; Pardoll D; Hung CF; Wu TC
Gene Ther; 2006 Jan; 13(1):67-77. PubMed ID: 16107858
[TBL] [Abstract][Full Text] [Related]
9. A combination of DNA vaccines targeting human papillomavirus type 16 E6 and E7 generates potent antitumor effects.
Peng S; Tomson TT; Trimble C; He L; Hung CF; Wu TC
Gene Ther; 2006 Feb; 13(3):257-65. PubMed ID: 16177818
[TBL] [Abstract][Full Text] [Related]
10. Development of a DNA vaccine targeting human papillomavirus type 16 oncoprotein E6.
Peng S; Ji H; Trimble C; He L; Tsai YC; Yeatermeyer J; Boyd DA; Hung CF; Wu TC
J Virol; 2004 Aug; 78(16):8468-76. PubMed ID: 15280455
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity.
Lin CT; Tsai YC; He L; Yeh CN; Chang TC; Soong YK; Monie A; Hung CF; Lai CH
Immunol Lett; 2007 Dec; 114(2):86-93. PubMed ID: 17976741
[TBL] [Abstract][Full Text] [Related]
12. Treatment with demethylating agent, 5-aza-2'-deoxycytidine enhances therapeutic HPV DNA vaccine potency.
Lu D; Hoory T; Monie A; Wu A; Wang MC; Hung CF
Vaccine; 2009 Jul; 27(32):4363-9. PubMed ID: 19481843
[TBL] [Abstract][Full Text] [Related]
13. Intravaginal HPV DNA vaccination with electroporation induces local CD8+ T-cell immune responses and antitumor effects against cervicovaginal tumors.
Sun Y; Peng S; Qiu J; Miao J; Yang B; Jeang J; Hung CF; Wu TC
Gene Ther; 2015 Jul; 22(7):528-35. PubMed ID: 25786869
[TBL] [Abstract][Full Text] [Related]
14. Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination.
Chuang CM; Monie A; Hung CF; Wu TC
J Biomed Sci; 2010 Apr; 17(1):32. PubMed ID: 20426849
[TBL] [Abstract][Full Text] [Related]
15. Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis.
Cheng WF; Hung CF; Chen CA; Lee CN; Su YN; Chai CY; Boyd DA; Hsieh CY; Wu TC
Vaccine; 2005 May; 23(29):3864-74. PubMed ID: 15893626
[TBL] [Abstract][Full Text] [Related]
16. Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts.
Tseng CW; Trimble C; Zeng Q; Monie A; Alvarez RD; Huh WK; Hoory T; Wang MC; Hung CF; Wu TC
Cancer Immunol Immunother; 2009 May; 58(5):737-48. PubMed ID: 18815785
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulin.
Hsieh CJ; Kim TW; Hung CF; Juang J; Moniz M; Boyd DA; He L; Chen PJ; Chen CH; Wu TC
Vaccine; 2004 Sep; 22(29-30):3993-4001. PubMed ID: 15364449
[TBL] [Abstract][Full Text] [Related]
18. Combined prophylactic and therapeutic intranasal vaccination against human papillomavirus type-16 using different adeno-associated virus serotype vectors.
Nieto K; Kern A; Leuchs B; Gissmann L; Müller M; Kleinschmidt JA
Antivir Ther; 2009; 14(8):1125-37. PubMed ID: 20032542
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen.
Cheng WF; Hung CF; Chai CY; Hsu KF; He L; Ling M; Wu TC
J Clin Invest; 2001 Sep; 108(5):669-78. PubMed ID: 11544272
[TBL] [Abstract][Full Text] [Related]
20. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
Seo SH; Jin HT; Park SH; Youn JI; Sung YC
Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]